跳至主要内容
临床试验/EUCTR2019-004831-21-NO
EUCTR2019-004831-21-NO进行中(未招募)1 期

10 to 12 year extended follow-up of the SCHEDULE study (SCANDINAVIAN HEART TRANSPLANT EVEROLIMUS DE NOVO STUDY WITH EARLY CNI AVOIDANCE) - SCHEDULE 10 years

Oslo University Hospital0 个研究点目标入组 120 人开始时间: 2019年12月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patients who
  • 1)participated in the SCHEDULE 12-month main study, and who
  • 2) are coming for a regular annual clinic visit 10 to 12 years after randomization in the main study
  • 3) are willing to provide a separate signed patient informed consent for this follow-up study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • Patients with a cardiac retransplant since the original SCHEDULE study

研究者

发起方
Oslo University Hospital

相似试验